FirmaIQ
Org.nr 985 889 635 2006 → 2007 Year-over-year analysis

LYTIX BIOPHARMA ASA: årsregnskap 2007 vs 2006

Shrank 19% on revenue, weaker earnings

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2007 with 2006 for LYTIX BIOPHARMA ASA. Revenue 285.0k NOK → 231.7k NOK (-18.7%). Net result -8.09m NOK → -15.16m NOK. Equity 15.90m NOK → 48.42m NOK.

On the constructive side: equity strengthened; cash rose. Pressures included: revenue fell; operating result weakened; net result weakened.

Mixed year — gains and pressures both show up.

At a glance

Scorecard

Revenue
285.0k NOK 231.7k NOK
-18.7%
Operating result
-8.27m NOK -15.45m NOK
-86.8%
Net result
-8.09m NOK -15.16m NOK
-87.5%
Equity
15.90m NOK 48.42m NOK
+204.6%
Cash
16.13m NOK 48.20m NOK
+198.9%
Total assets
18.55m NOK 54.96m NOK
+196.3%

What improved

  • ↑

    Equity strengthened

    Book equity 15.90m NOK → 48.42m NOK (equity ratio 85.7% → 88.1%). Calculated

  • ↑

    Cash rose

    Bank deposits 16.13m NOK → 48.20m NOK (+198.9% YoY). Calculated

What deteriorated

  • ↓

    Revenue fell

    Operating income / revenue moved from 285.0k NOK to 231.7k NOK (-18.7% YoY). Calculated

  • ↓

    Operating result weakened

    Operating result -8.27m NOK → -15.45m NOK (op. margin -2902.0% → -6668.8%). Calculated

  • ↓

    Net result weakened

    Net result -8.09m NOK → -15.16m NOK (net margin -2837.8% → -6545.5%). Calculated